Use of Plant-Based Absorbable Hemostatic Powder and Intravenous Tranexamic Acid in Breast Reduction Patients Reduces Hematoma Rates
IV TXA significantly reduces postoperative hematoma rates following reduction mammaplasty, with the addition of Arista providing a modest incremental benefit. Although TXA remains the primary agent for hematoma prophylaxis, Arista may be selectively useful in patients contraindicated for TXA. Further prospective studies are warranted.
Authors
- Orr Shauly (ORCID: https://orcid.org/0000-0002-1714-8998)
- Anjali Om (ORCID: https://orcid.org/0000-0002-0085-9574)
- Gabriela García Nores
- Daniel Cuzzone (ORCID: https://orcid.org/0000-0003-1131-7305)
- Albert Losken
- Bo Hyun Kong (ORCID: https://orcid.org/0009-0001-2355-305X)
Institutions
- Emory University (US)
Publication Details
- Journal
- Annals of Plastic Surgery
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1097/sap.0000000000004586
- Primary Topic
- Breast Implant and Reconstruction
- Type
- article
- Field-Weighted Citation Impact
- 0.00